JPH0510129B2 - - Google Patents
Info
- Publication number
- JPH0510129B2 JPH0510129B2 JP59180177A JP18017784A JPH0510129B2 JP H0510129 B2 JPH0510129 B2 JP H0510129B2 JP 59180177 A JP59180177 A JP 59180177A JP 18017784 A JP18017784 A JP 18017784A JP H0510129 B2 JPH0510129 B2 JP H0510129B2
- Authority
- JP
- Japan
- Prior art keywords
- protein
- amino acid
- producing
- emulsifier
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000018102 proteins Nutrition 0.000 claims description 48
- 102000004169 proteins and genes Human genes 0.000 claims description 48
- 108090000623 proteins and genes Proteins 0.000 claims description 48
- 239000003995 emulsifying agent Substances 0.000 claims description 42
- 235000001014 amino acid Nutrition 0.000 claims description 33
- 150000001413 amino acids Chemical class 0.000 claims description 19
- 238000000108 ultra-filtration Methods 0.000 claims description 13
- 238000000502 dialysis Methods 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 108010059378 Endopeptidases Proteins 0.000 claims description 6
- 102000005593 Endopeptidases Human genes 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 108010013296 Sericins Proteins 0.000 claims description 4
- 229920002494 Zein Polymers 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 238000011033 desalting Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000005019 zein Substances 0.000 claims description 4
- 229940093612 zein Drugs 0.000 claims description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 108010076119 Caseins Proteins 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108010058846 Ovalbumin Proteins 0.000 claims description 2
- 108010071390 Serum Albumin Proteins 0.000 claims description 2
- 102000007562 Serum Albumin Human genes 0.000 claims description 2
- 108010055615 Zein Proteins 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical group NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229940092253 ovalbumin Drugs 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 32
- 229940024606 amino acid Drugs 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- 230000001804 emulsifying effect Effects 0.000 description 13
- 230000003020 moisturizing effect Effects 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000006911 enzymatic reaction Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000005907 alkyl ester group Chemical group 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 230000009965 odorless effect Effects 0.000 description 6
- 239000003513 alkali Substances 0.000 description 5
- -1 amino acid ester Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000005185 salting out Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000001877 deodorizing effect Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 101710097834 Thiol protease Proteins 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 125000001165 hydrophobic group Chemical group 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940066758 endopeptidases Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940043348 myristyl alcohol Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- MKPPFDFPOPEGQC-UHFFFAOYSA-N octadecyl 2-aminoacetate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CN MKPPFDFPOPEGQC-UHFFFAOYSA-N 0.000 description 2
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 108090000624 Cathepsin L Proteins 0.000 description 1
- 102000004172 Cathepsin L Human genes 0.000 description 1
- 108090000613 Cathepsin S Proteins 0.000 description 1
- 102100035654 Cathepsin S Human genes 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical group CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000010701 ester synthesis reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 108010078692 yeast proteinase B Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/30—Proteins; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/16—Amines or polyamines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- General Preparation And Processing Of Foods (AREA)
Description
(技術分野)
本発明は、皮膚等に対する刺激が少なく且つ乳
化作用が強く、しかも保湿性を備えた蛋白質系乳
化剤を効率良く製造する方法に関する。
(背景技術)
一般に、乳化剤は、化粧料や食品等に広く用い
られている。化粧料に用いられる乳化剤として
は、アニオン界面活性剤やノニオン界面活性剤が
あげられる。しかし、アニオン界面活性剤は皮膚
刺激があり、ノニオン界面活性剤も乳化性が充分
でなかつたり、多少の皮膚刺激を有するという難
点がある。さらに、この種の乳化剤は、クリーム
等に対して保水性を付与することができないた
め、グリセリン等の保湿剤を添加しているのが現
状であるが、それによつて乳化安定性や感触が変
わるという問題点がある。
また、食品の乳化剤としては、シユガーエステ
ルや脂肪酸のモノグリセライド等が用いられてい
るが、これらの乳化剤は乳化作用があまり強くな
く、充分な乳化作用を発揮させるためには多量の
乳化剤を使用しなければならないという難点を有
している。したがつて、皮膚に対する刺激が少な
く、乳化作用が強く、保湿性を備えた乳化剤が強
く望まれている。
本発明者らは、本願に先立つて、親水性蛋白質
分解物のカルボキシ末端とアミノ酸アルキルエス
テル−p−トルエンスルフオン酸塩のアミノ基部
分をアミド結合させて蛋白質系乳化剤を製造する
方法を提案している〔昭和58年特許願第201823号
(特開昭60−94124号公報)〕。この蛋白質系乳化剤
は、皮膚に対する刺激が少なく、乳化作用が強
く、しかも保湿性を備えている。
しかし、この方法で用いられるアミノ酸アルキ
ルエステル−p−トルエンスルフオン酸塩は、エ
ンドペプチダーゼの存在下において、親水性蛋白
質と反応するに際して、溶媒である緩衝液−アセ
トン混液に対する溶解性が悪く、特にアルキル基
が長鎖になる程、均一系になり難くなる。したが
つて、蛋白質系乳化剤の反応収率が今一つとなつ
ていた。また、上記反応において、原料として使
用するアミノ酸アルキルエステル−p−トルエン
スルフオン酸塩は、その製造に際し、エステル合
成反応終了後、未反応の不純物を除去するため、
アセトン等の溶媒で、繰り返し再結晶化して精製
される。しかしながら、未反応のアミノ酸、p−
トルエンスルフオン酸等の不純物を充分に除去す
ることは困難であり、それらが不純物として残存
する。このような不純物を含むアミノ酸アルキル
エステル−p−トルエンスルフオン酸塩をグラフ
ト剤として使用すると、目的とする蛋白質系乳化
剤への転化率が低くなるうえ、含有不純物が、得
られる蛋白質系乳化剤に混入するため、蛋白質系
乳化剤を最終工程において熱アセトン等で何回も
繰り返し洗浄しなければならなかつた。
このような問題を解決するため、さらに研究を
重ねた結果、本発明者らは、アミノ酸アルキルエ
ステル−p−トルエンスルフオン酸塩を、アルカ
リ処理または塩析条件下、アルカリ処理して遊離
のアミノ酸アルキルエステルを得、これを蛋白質
のグラフト反応に適用すると、前記アミノ酸やp
−トルエンスルフオン酸等の未反応不純物の除去
の問題および反応系における溶解性の問題が改善
され、蛋白質系乳化剤が好収率で得られること、
更にそれを透析することにより、無臭の蛋白質系
乳化剤を得られることを見い出し、本発明を完成
するに到つた。
(発明の目的)
従つて本発明の目的とするところは、皮膚に対
する刺激が少なく且つ乳化作用が強く、しかも保
湿性を備えた蛋白質系乳化剤を効率良く製造する
方法を提供するにある。
他の目的及び効果は以下の説明から明らかにさ
れよう。
(発明の開示)
上述の目的は、アミノ酸と脂肪族アルコールを
p−トルエンスルフオン酸触媒下反応させた後、
アルカリ性媒質で脱塩して得られる下記一般式で
示されるアミノ酸アルキルエステルのアミノ基部
分を、親水性蛋白質分解物のカルボキシル末端に
アミド結合せしめることを特徴とする蛋白質系乳
化剤の製造法、及びこの方法によつて得られた反
応生成物を更に透析することを特徴とする蛋白質
系乳化剤の製造法により達成される。
R1・OR2 ……(1)
(ただし、式中R1及びR2は前記に同じ)
上記一般式(1)に於いてR1で示されるアミノ酸
残基とは、アミノ酸のカルボキシル基(−
COOH)からOHを除いた部分
(Technical Field) The present invention relates to a method for efficiently producing a protein-based emulsifier that is less irritating to the skin, has a strong emulsifying effect, and has moisturizing properties. (Background Art) Generally, emulsifiers are widely used in cosmetics, foods, and the like. Examples of emulsifiers used in cosmetics include anionic surfactants and nonionic surfactants. However, anionic surfactants cause skin irritation, and nonionic surfactants also have drawbacks in that they do not have sufficient emulsifying properties or cause some skin irritation. Furthermore, since this type of emulsifier cannot impart water retention properties to creams, etc., moisturizing agents such as glycerin are currently added, but this changes the emulsion stability and texture. There is a problem. In addition, sugar esters and monoglycerides of fatty acids are used as emulsifiers in foods, but these emulsifiers do not have a very strong emulsifying effect, and a large amount of emulsifying agent must be used to achieve sufficient emulsifying effect. It has the disadvantage that it must be done. Therefore, there is a strong desire for emulsifiers that are less irritating to the skin, have a strong emulsifying effect, and have moisturizing properties. Prior to this application, the present inventors proposed a method for producing a protein-based emulsifier by bonding the carboxy terminus of a hydrophilic protein decomposition product with the amino group of an amino acid alkyl ester p-toluenesulfonate through an amide bond. [Patent Application No. 201823 (1982) (Japanese Patent Application Laid-Open No. 1983-94124)]. This protein-based emulsifier is less irritating to the skin, has a strong emulsifying effect, and has moisturizing properties. However, when the amino acid alkyl ester p-toluenesulfonate used in this method reacts with hydrophilic proteins in the presence of endopeptidase, it has poor solubility in the solvent, a buffer-acetone mixture, and is particularly The longer the alkyl group becomes, the more difficult it becomes to form a homogeneous system. Therefore, the reaction yield of protein-based emulsifiers has been unsatisfactory. In addition, in the above reaction, the amino acid alkyl ester p-toluenesulfonate used as a raw material is manufactured by removing unreacted impurities after the ester synthesis reaction is completed.
It is purified by repeated recrystallization with solvents such as acetone. However, unreacted amino acids, p-
It is difficult to sufficiently remove impurities such as toluenesulfonic acid, and they remain as impurities. If an amino acid alkyl ester p-toluenesulfonate containing such impurities is used as a grafting agent, the conversion rate to the desired protein-based emulsifier will be low, and the impurities will be mixed into the resulting protein-based emulsifier. Therefore, the protein-based emulsifier had to be washed many times with hot acetone or the like in the final step. In order to solve these problems, as a result of further research, the present inventors treated amino acid alkyl ester-p-toluenesulfonate with alkali or under salting-out conditions to obtain free amino acids. When alkyl esters are obtained and applied to protein grafting reactions, the amino acids and
- The problem of removing unreacted impurities such as toluenesulfonic acid and the problem of solubility in the reaction system are improved, and a protein-based emulsifier can be obtained in a good yield;
Furthermore, the inventors discovered that an odorless protein-based emulsifier can be obtained by dialysis, and have completed the present invention. (Object of the Invention) Therefore, an object of the present invention is to provide a method for efficiently producing a protein-based emulsifier that is less irritating to the skin, has a strong emulsifying effect, and has moisturizing properties. Other objects and advantages will become apparent from the description below. (Disclosure of the Invention) The above object is to react an amino acid and an aliphatic alcohol under p-toluenesulfonic acid catalyst, and then
A method for producing a protein-based emulsifier, characterized in that the amino group portion of an amino acid alkyl ester represented by the following general formula obtained by desalting in an alkaline medium is bonded with an amide bond to the carboxyl terminal of a hydrophilic protein decomposition product, and this This is achieved by a method for producing a protein-based emulsifier, which is characterized in that the reaction product obtained by the method is further dialyzed. R 1・OR 2 ...(1) (However, in the formula, R 1 and R 2 are the same as above.) In the above general formula (1), the amino acid residue represented by R 1 means the carboxyl group of the amino acid ( −
COOH) minus OH
【式】を
意味する。
本発明に係る上記一般式(1)にて示されるアミノ
酸エステルとしては、例えばグリシン、アラニ
ン、フエニルアラニン等の疎水性が高く、直鎖状
のアルキル基を有するアミノ酸、バリン、ロイシ
ン、イソロイシン、ノルロイシン、プロリン等の
疎水性は高いが分岐のあるアルキル基を有するア
ミノ酸、リジン、オルニチン、ヒスチジン等の上
記以外のアミノ酸、等のアミノ酸類のカルボキシ
ル基が、ミリスチルアルコール、ペンタデシルア
ルコール、セチルアルコール、2−ヘキシルデカ
ノール、ヘプタデシルアルコール、ステアリルア
ルコール、イソステアリルアルコール、アラキル
アルコール、2−オクチルドデカノール、ベヘニ
ルアルコール等の炭素数14〜22のアルコール等の
アルコール類のアルコキシ基によつて置換された
化合物が好ましいものとして挙げられる。
本発明に用いられるアルカリ性媒質としては、
NaOHまたはKOH水溶液を用いることが好まし
い。アルカリ濃度は、好ましくは0.01N〜5N、
さらに好ましくは0.05N〜2Nである。また、上
記アルカリ処理は塩類との共存下で塩析により行
うことが好ましい。塩析用の塩としては、アルカ
リ金属塩、アンモニウム塩等があり、具体的には
例えば塩化ナトリウム、塩化カリウム、炭酸カリ
ウム、リン酸カリウム、硫酸アンモニウム、硫酸
ナトリウム等があげられるが、塩化ナトリウムお
よび塩化カリウムが好適である。塩析の塩濃度
は、通常0.5%〜25%の範囲であり、好ましくは
1%〜10%である。
上記アミノ酸アルキルエステル−p−トルエン
スルフオン酸塩は固体であるが、このようにして
得られた遊離のアミノ酸アルキルエステルは、油
状または融点の低い固体状態のものであり、後述
する親水性蛋白質との反応の際、反応系溶媒とし
て用いられる緩衝液−アセトン混液等に対し、溶
解性が極めてよく、均一系で反応し得る為、親水
性蛋白質との反応効率が大幅に向上する。
また、本発明に適用される親水性蛋白質として
は、例えばカゼイン、ゼラチン、セリシン、可溶
性コラーゲン、ゼイン、血清アルブミン、ラクト
アルブミン、卵白アルブミン等が挙げられ、これ
らは単独でもしくは併せて用いられる。これらの
蛋白質のうち、セリシン以外の蛋白質は、試薬と
して販売されている。また、セリシンは切り繭か
ら熱水抽出し凍結乾燥することにより得ることが
できる。
また、酵素反応に用いられるエンドペプチダー
ゼは蛋白質をその中央部分より切断する作用を備
えており、これには、セリンプロテアーゼ、チオ
ールプロテアーゼ、カルボキシルプロテアーゼ、
金属プロテアーゼ、その他のエンドペプチダーゼ
が含まれる。これらのうち、チオールプロテアー
ゼを用いることが最も好ましい。このチオールプ
ロテアーゼとして、パパイン、カテプシンB、ブ
ロメライン、キモパパイン、カテプシンL、酵母
プロテナーゼB、カテプシンS、TZ−ペプチダ
ーゼ等が挙げられ、これらは単独もしくは併せて
用いられる。
蛋白質系乳化剤は、前述したアミノ酸アルキル
エステルと親水性蛋白質を、上記エンドペプチダ
ーゼの存在下で反応させることによつて得られ
る。
かくして得られた酵素反応生成物は、エンドペ
プチダーゼ活性を酸性条件で失活後透析する。透
析に際しては、ホロフアイバー型限外濾過膜、特
に円形ハウジングに収納されたホロフアイバー型
限外濾過膜によつて行うと好適な結果が得られ
る。ホロフアイバー型の限外濾過膜の材質として
は、酢酸セルロース、セルロース、ポリアクリロ
ニトリル、エチレンビニルアルコール、ポリビニ
ルアルコール、クプロフアン膜(西独Enka社製)
等が使用され、好ましくはセルロース、ポリアク
リロニトリル、クプロフアン膜が選択される。
前記、ホロフアイバー型の限外濾過膜で透析及
び濃縮する際、酵素反応生成物は、好ましくは25
℃〜50℃、更に好ましくは35℃〜45℃に保温する
のが好ましい。
このホロフアイバー型の限外濾過装置で、透
析、濃縮を行うことにより、脱臭が完全に行わ
れ、尚且つ非常に短時間に脱塩、濃縮が実施でき
る。
更に、後の操作の乾燥工程も、前記濃縮工程で
水分含量が少なくなつた為、経済的且つ短時間に
処理することができ、目的とする無臭の蛋白質系
乳化剤が短時間且つ経済的に、そして大量に得ら
れる。
(発明の効果)
本発明は、アミノ酸アルキルエステル−p−ト
ルエンスルフオン酸塩を一旦脱塩している為、目
的生産物を高収率で得ることができる。またこの
蛋白質系乳化剤は、親水基部分が本質的に強い親
水性をもつ蛋白質からなり、疎水基部分が疎水性
のアミノ酸アルキルエステルからなつていて、典
型的な界面活性剤構造となつている(親水基部分
の後端に疎水基部分の前端が結合しており、中間
部分等に余分な疎水基部分が結合していない)た
め、強力な乳化力を有する。しかもこの乳化作用
は、蛋白質部分の高分子構造に基づき殆ど温度に
よる影響を受けないため、この乳化剤では、特に
低温における乳化作用の低下現象が生じない。そ
して、上記親水基部分は分子量が比較的大きい
(分子量約500以上、通常は数千)ため、乳化剤全
体の分子量が大きくなつており、皮膚等に対する
刺激を殆ど与えない。そのうえ、特にこの乳化剤
は、親水基部分が本質的に保湿力を有する蛋白質
からなつているため、充分な保湿性を備えてい
る。したがつて、これを化粧料、特にクリームに
用いると、これまでのような多価アルコール等の
保湿剤を用いることなく、充分な保水性を付与し
うるようになる。
また、本発明方法によつて、透析された蛋白質
系乳化剤は、無臭であるため無賦香でも異和感な
く使用可能であるとともに、賦香に際しても本来
の香料の持つ匂いを損うことなく賦香が可能とな
つた。
このように、上記蛋白質系乳化剤は、皮膚等に
対する刺激が少なく、かつ乳化作用が強くしかも
保湿性を備えているため、例えば化粧料に用いた
場合には、優れた効果が得られるようになる。ま
た、これを食品の乳化剤として利用する場合に
は、その強力な乳化作用により乳化剤の使用量を
低減させうるようになる。しかも、この乳化剤
は、その構成部分の殆どが天然物由来物であるた
め、繰り返し摂取しても何ら問題を生じない。
更に、無臭の蛋白質系乳化剤は、食品において
も重要な味覚や臭覚に異和感を与えることなく摂
取される。
以下実施例を挙げて本発明を具体的に説明す
る。
実施例 1
アミノ酸アルキルエステルを下記のようにして
製造し、つぎにこれを酵素反応に供した。
(アミノ酸アルキルエステルの合成)
アミノ酸としてロイシンを0.05mol採取すると
ともに、p−トルエンスルフオン酸・1水和物を
0.055mol採取し、さらにアルコールとしてミリ
スチルアルコールを0.075mol採取し、これに溶
剤としてのベンゼンを加えて充分攪拌混合し、ベ
ンゼンの還流温度で加熱還流させエステル化反応
を進めた。この場合、そのエステル化反応の進行
に伴つて生じた水がベンゼンと共沸状態で出てく
るので、それを反応系外に除きながら約5〜10時
間で反応を完了させた。
室温冷却後、その反応溶液を0.3NNaOHを含
む3%NaCl溶液で3度洗浄し、脱塩を行つた。
その後ベンゼン層を採取し、中性になるまで充
分3%塩水で洗浄した。軽く水洗後、ベンゼン層
を採取し、無水硫酸ナトリウムにて一晩乾燥し
た。乾燥後ベンゼン層を濾取し、このベンゼン溶
液をエバポレーターで溶媒除去し、精製された遊
離のロイシンミリスチルエステルの油状物質を得
た。
(酵素反応)
1M濃度の炭酸緩衝液(PH9.0)480mlに親水性
蛋白質であるゼラチン120gを溶解し、これに120
mlのアセトンを添加し、37℃の温水バスに浸漬
し、充分に攪拌して均一化した。つぎに、これに
前記の様にして得られたロイシンミリスチルエス
テル39.3g(ゼラチン1000gに対して1molにな
る量)を添加して充分に攪拌し均一化した。この
場合、ロイシンミリスチルエステルのようなアミ
ノ酸アルキルエステルは、ゼラチンのような親水
性蛋白質1000gに対して1molの割合になるよう
に添加することが反応効率上好ましい。ついで、
これに、L−システイン塩酸塩(和光純薬製)
1.05gを加え、さらに、エンドペプチダーゼであ
るパパイン(シグマ社製)60mgを添加して攪拌し
ながら15分間反応させた。そして、2N塩酸を用
いて全体のPHを2にして反応をとめた。反応溶液
として、約1.5となつた。
(精製)
上記反応溶液を約40℃に保温し、ホロフアイバ
ー型限外濾過装置(クプロフアン膜、フアイバー
内径200μ、膜厚11μ、有効膜面積1.5m2)に約10
ml/minの流速で送液し、外液は約40℃の温水を
約1/minの流速で送液した。透析後、同じホ
ロフアイバー型限外濾過装置の内圧を約2Kg/cm2
にし、前記と同条件下で透析溶液を濃縮し、最終
的に約700ml得た。
この濃縮液を噴霧乾燥装置で乾燥させ、無臭の
蛋白質系乳化剤として約85gを得た。
実施例 2
アミノ酸アルキルエステルを下記のようにして
製造し、つぎにこれを酵素反応に供する。
(アミノ酸アルキルエステルの合成)
アミノ酸としてグリシンを0.05mol採取すると
ともに、p−トルエンスルフオン酸・1水和物を
0.055mol採取し、さらにアルコールとしてステ
アリルアルコールを0.075mol採取し、これに溶
剤としてのベンゼンを加えて充分攪拌混合し、ベ
ンゼンの還流温度で加熱還流させてエステル化反
応を進めた。この場合、そのエステル化反応の進
行に伴つて生じた水がベンゼンと共沸状態で出て
くるので、それを反応系外に除きながら約7時間
で反応を完了させた。
つぎに、反応溶液を室温に冷却後、
0.5NNaOHを含む3%NaCl溶液300mlを加え、
塩析条件下、アルカリ処理を行つて脱塩した。ア
ルカリ処理は3度繰り返した。その後、ベンゼン
層を採取し、充分3%食塩水で洗浄した。その後
の工程は、実施例1同様に処理し、精製された遊
離のグリシンステアリルエステルの油状物質を得
た。
(酵素反応)
ゼラチン120gに代えてゼイン70gを用い、こ
れを1Mの炭酸緩衝液480mlに溶解した。ついで、
これに120mlのアセトンを加え、35℃の温水バス
に浸漬して攪拌均一化したのち、前もつて50℃で
溶融させておいたグリシン−ステアリルエステル
19.0gを添加(ゼイン1000gに対し1molになる
量)し、攪拌均一化した。ついで、これに、L−
システイン塩酸塩(和光純薬製)1.05gを加え、
さらに、エンドペプチダーゼであるパパイン(シ
グマ社製)45mgを添加して攪拌しながら15分間反
応させた。そして、2N塩酸を用いて全体のPHを
2にして反応をとめた。反応溶液として約1.5
となつた。
(精製)
上記反応溶液を約40℃に保温し、ホロフアイバ
ー型限外濾過装置(セルロース膜、フアイバー内
径200μ、膜厚11μ、有効膜面積2.4m2)に約10ml/
minの流速で送液し、外液は約40℃の温水を約1
/minの流速で送液した。透析後、同じホロフ
アイバー型限外濾過装置の内圧を約2Kg/cm2に
し、前記と同条件下で透析溶液を濃縮し、最終的
に約600ml得た。
この濃縮液を噴霧乾燥装置で乾燥させ、無臭の
蛋白質系乳化剤として約63gを得た。
実施例1及び2において、ホロフアイバー型限
外濾過装置による透析プロセスでの透析効率を卓
上用デジタル導電率計(電気化学計器(株)A0−6
型)で溶液の導電率から検討比較した結果を第1
表に示す。It means [formula]. The amino acid ester represented by the above general formula (1) according to the present invention includes, for example, highly hydrophobic amino acids having a linear alkyl group such as glycine, alanine, and phenylalanine, valine, leucine, isoleucine, Amino acids with highly hydrophobic but branched alkyl groups such as norleucine and proline, amino acids other than those listed above such as lysine, ornithine, and histidine, etc. The carboxyl group of amino acids such as myristyl alcohol, pentadecyl alcohol, cetyl alcohol, Compounds substituted with an alkoxy group of alcohols such as alcohols having 14 to 22 carbon atoms such as 2-hexyldecanol, heptadecyl alcohol, stearyl alcohol, isostearyl alcohol, aracyl alcohol, 2-octyldodecanol, behenyl alcohol, etc. These are listed as preferred. The alkaline medium used in the present invention includes:
Preferably, an aqueous NaOH or KOH solution is used. Alkali concentration is preferably 0.01N to 5N,
More preferably, it is 0.05N to 2N. Further, the alkali treatment is preferably carried out by salting out in the presence of salts. Salts for salting out include alkali metal salts, ammonium salts, etc. Specific examples include sodium chloride, potassium chloride, potassium carbonate, potassium phosphate, ammonium sulfate, sodium sulfate, etc. Potassium is preferred. The salt concentration in salting out is usually in the range of 0.5% to 25%, preferably 1% to 10%. The amino acid alkyl ester-p-toluenesulfonate mentioned above is a solid, but the free amino acid alkyl ester obtained in this way is in an oily state or a solid state with a low melting point, and is a hydrophilic protein as described below. During the reaction, it has extremely good solubility in the buffer-acetone mixture used as the reaction solvent and can react in a homogeneous system, so the reaction efficiency with hydrophilic proteins is greatly improved. Examples of hydrophilic proteins applicable to the present invention include casein, gelatin, sericin, soluble collagen, zein, serum albumin, lactalbumin, and ovalbumin, which may be used alone or in combination. Among these proteins, proteins other than sericin are sold as reagents. Furthermore, sericin can be obtained by hot water extraction from cut cocoons and freeze-drying. In addition, endopeptidases used in enzymatic reactions have the ability to cleave proteins from their central parts, and include serine proteases, thiol proteases, carboxyl proteases,
Includes metalloproteases and other endopeptidases. Among these, it is most preferable to use thiol protease. Examples of the thiol protease include papain, cathepsin B, bromelain, chymopapain, cathepsin L, yeast proteinase B, cathepsin S, and TZ-peptidase, which may be used alone or in combination. The protein emulsifier can be obtained by reacting the above-mentioned amino acid alkyl ester with a hydrophilic protein in the presence of the above-mentioned endopeptidase. The enzyme reaction product thus obtained is dialyzed after the endopeptidase activity is inactivated under acidic conditions. Favorable results can be obtained when dialysis is carried out using a holofiber type ultrafiltration membrane, particularly a holofiber type ultrafiltration membrane housed in a circular housing. Materials for the holofiber type ultrafiltration membrane include cellulose acetate, cellulose, polyacrylonitrile, ethylene vinyl alcohol, polyvinyl alcohol, and cuprofan membrane (manufactured by Enka, Germany).
etc., and preferably cellulose, polyacrylonitrile, cuprofan membranes are selected. When dialyzing and concentrating using the holofiber type ultrafiltration membrane, the enzyme reaction product is preferably 25
It is preferable to keep the temperature at 35°C to 45°C, more preferably 35°C to 45°C. By performing dialysis and concentration using this holofiber type ultrafiltration device, deodorization can be completely performed, and desalination and concentration can be performed in a very short time. Furthermore, the subsequent drying process can be carried out economically and quickly because the water content is reduced in the concentration process, and the desired odorless protein emulsifier can be processed quickly and economically. And you can get it in large quantities. (Effects of the Invention) In the present invention, since the amino acid alkyl ester p-toluenesulfonate is once desalted, the desired product can be obtained in high yield. In addition, this protein-based emulsifier has a typical surfactant structure, with the hydrophilic group consisting of a protein that inherently has strong hydrophilicity and the hydrophobic group consisting of a hydrophobic amino acid alkyl ester ( The front end of the hydrophobic group is bonded to the rear end of the hydrophilic group, and no extra hydrophobic group is bonded to the middle portion, etc.), so it has strong emulsifying power. Furthermore, since this emulsifying effect is hardly affected by temperature due to the polymer structure of the protein moiety, this emulsifier does not cause a decrease in the emulsifying effect, especially at low temperatures. Since the hydrophilic group portion has a relatively large molecular weight (about 500 or more, usually several thousand), the entire emulsifier has a large molecular weight and hardly irritates the skin. Moreover, this emulsifier in particular has sufficient moisturizing properties because the hydrophilic group portion essentially consists of proteins that have moisturizing properties. Therefore, when this is used in cosmetics, especially creams, sufficient water retention can be imparted without using conventional humectants such as polyhydric alcohols. In addition, the protein-based emulsifier dialyzed by the method of the present invention is odorless, so it can be used without any discomfort, and even when flavored, the original scent of the fragrance will not be lost. It became possible to add incense. As described above, the above protein-based emulsifiers cause less irritation to the skin, etc., have strong emulsifying effects, and have moisturizing properties, so when used in cosmetics, for example, excellent effects can be obtained. . Furthermore, when this is used as an emulsifier for foods, the amount of emulsifier used can be reduced due to its strong emulsifying effect. Furthermore, since most of the constituent parts of this emulsifier are derived from natural products, no problem will occur even if the emulsifier is repeatedly ingested. Furthermore, the odorless protein-based emulsifier can be ingested without causing any discomfort to the sense of taste or smell, which is important in foods. The present invention will be specifically explained below with reference to Examples. Example 1 An amino acid alkyl ester was produced as described below, and then subjected to an enzymatic reaction. (Synthesis of amino acid alkyl ester) Collect 0.05 mol of leucine as an amino acid and add p-toluenesulfonic acid monohydrate.
0.055 mol was collected, and further 0.075 mol of myristyl alcohol was collected as an alcohol, benzene as a solvent was added thereto, the mixture was thoroughly stirred and mixed, and the mixture was heated to reflux at the reflux temperature of benzene to proceed with the esterification reaction. In this case, since water produced as the esterification reaction progressed came out in an azeotropic state with benzene, the reaction was completed in about 5 to 10 hours while removing it from the reaction system. After cooling to room temperature, the reaction solution was washed three times with a 3% NaCl solution containing 0.3N NaOH to perform desalting. Thereafter, the benzene layer was collected and thoroughly washed with 3% salt water until it became neutral. After washing lightly with water, the benzene layer was collected and dried over anhydrous sodium sulfate overnight. After drying, the benzene layer was collected by filtration, and the solvent was removed from this benzene solution using an evaporator to obtain a purified oily substance of free leucine myristyl ester. (Enzyme reaction) Dissolve 120 g of gelatin, a hydrophilic protein, in 480 ml of 1M carbonate buffer (PH9.0), and add 120 g of gelatin to this
ml of acetone was added, immersed in a 37°C hot water bath, and thoroughly stirred to homogenize. Next, 39.3 g of leucine myristyl ester obtained as described above (an amount of 1 mol per 1000 g of gelatin) was added thereto, and the mixture was sufficiently stirred to homogenize. In this case, the amino acid alkyl ester such as leucine myristyl ester is preferably added at a ratio of 1 mol to 1000 g of hydrophilic protein such as gelatin in terms of reaction efficiency. Then,
In addition, L-cysteine hydrochloride (manufactured by Wako Pure Chemical Industries, Ltd.)
1.05 g was added, and further 60 mg of endopeptidase papain (manufactured by Sigma) was added and reacted for 15 minutes with stirring. Then, the overall pH was adjusted to 2 using 2N hydrochloric acid to stop the reaction. The reaction solution was approximately 1.5. (Purification) The above reaction solution was kept at about 40°C and filtered into a holofiber type ultrafiltration device (Cuprofan membrane, fiber inner diameter 200μ, membrane thickness 11μ, effective membrane area 1.5m 2 ) for about 10 minutes.
The liquid was fed at a flow rate of ml/min, and the external liquid was warm water at about 40°C at a flow rate of about 1/min. After dialysis, the internal pressure of the same holofiber type ultrafiltration device was set to approximately 2Kg/cm 2
The dialysis solution was then concentrated under the same conditions as above, and approximately 700 ml was finally obtained. This concentrated solution was dried using a spray dryer to obtain about 85 g of an odorless protein-based emulsifier. Example 2 An amino acid alkyl ester is produced as follows, and then subjected to an enzymatic reaction. (Synthesis of amino acid alkyl ester) Collect 0.05 mol of glycine as an amino acid and p-toluenesulfonic acid monohydrate.
0.055 mol was collected, and further 0.075 mol of stearyl alcohol was collected as alcohol, benzene as a solvent was added thereto, the mixture was thoroughly stirred and mixed, and the mixture was heated to reflux at the reflux temperature of benzene to proceed with the esterification reaction. In this case, since water produced as the esterification reaction progressed came out in an azeotropic state with benzene, the reaction was completed in about 7 hours while removing it from the reaction system. Next, after cooling the reaction solution to room temperature,
Add 300ml of 3% NaCl solution containing 0.5NNaOH,
Desalination was carried out by alkali treatment under salting-out conditions. The alkali treatment was repeated three times. Thereafter, the benzene layer was collected and thoroughly washed with 3% saline. The subsequent steps were carried out in the same manner as in Example 1 to obtain purified free glycine stearyl ester oil. (Enzyme reaction) 70 g of zein was used in place of 120 g of gelatin, and this was dissolved in 480 ml of 1M carbonate buffer. Then,
Add 120ml of acetone to this, immerse it in a hot water bath at 35°C, stir it to make it homogeneous, and then add the glycine-stearyl ester that was previously melted at 50°C.
19.0 g was added (an amount of 1 mol per 1000 g of zein) and stirred to homogenize. Then, to this, L-
Add 1.05g of cysteine hydrochloride (manufactured by Wako Pure Chemical Industries),
Furthermore, 45 mg of endopeptidase papain (manufactured by Sigma) was added and reacted for 15 minutes with stirring. Then, the overall pH was adjusted to 2 using 2N hydrochloric acid to stop the reaction. Approximately 1.5 as reaction solution
It became. (Purification) The above reaction solution was kept at about 40°C, and about 10 ml/ approx .
The liquid is pumped at a flow rate of 1 min, and the external liquid is warm water at about 40°C.
The liquid was delivered at a flow rate of /min. After dialysis, the internal pressure of the same holofiber type ultrafiltration device was set to about 2 Kg/cm 2 and the dialysis solution was concentrated under the same conditions as above to finally obtain about 600 ml. This concentrated solution was dried using a spray dryer to obtain about 63 g of an odorless protein-based emulsifier. In Examples 1 and 2, the dialysis efficiency in the dialysis process using a holofiber type ultrafiltration device was measured using a tabletop digital conductivity meter (Denki Kagaku Keiki Co., Ltd. A0-6).
The results of the study and comparison based on the conductivity of the solution using
Shown in the table.
【表】
第1表に示す様に1回の透析だけでも、ほとん
ど外液の水道水の導電率とほぼ同値を示し、期待
される透析効率が得られた。
(脱臭効果評価)
脱臭効果は、限外濾過処理前の反応溶液を対照
として臭いを臭覚により判定した。10名の専門員
によつて行ない、下記評価基準を以つて評価し
た。
1 強い臭い有り
2 かすかに臭い有り
3 臭いなし
その結果、実施例1及び2の脱臭効果評価は次
表の通りであつた。[Table] As shown in Table 1, even after just one dialysis, the conductivity of the external solution was almost the same as that of tap water, and the expected dialysis efficiency was obtained. (Evaluation of deodorizing effect) The deodorizing effect was determined by smell using the reaction solution before ultrafiltration treatment as a control. It was conducted by 10 experts and evaluated using the following evaluation criteria. 1: Strong odor 2: Slight odor 3: No odor As a result, the deodorizing effects of Examples 1 and 2 were evaluated as shown in the table below.
【表】
同表から、ホロフアイバー型の限外濾過膜によ
つて、はつきりと脱臭効果が認められた。
以上の様に本発明によつて、皮膚等に対する刺
激が少なく、かつ乳化作用が強く、しかも保湿性
を備えた蛋白質系乳化剤が効率良く得られ、更に
ホロフアイバー型の限外濾過膜を用いた透析、濃
縮により、該蛋白質系乳化剤を完全に脱臭するこ
とができる。[Table] From the same table, it was observed that the holofiber type ultrafiltration membrane had a cleansing and deodorizing effect. As described above, according to the present invention, a protein-based emulsifier that is less irritating to the skin, has a strong emulsifying effect, and has moisturizing properties can be efficiently obtained. The protein emulsifier can be completely deodorized by dialysis and concentration.
Claims (1)
スルフオン酸触媒下反応させた後、アルカリ性媒
質で脱塩して得られる下記一般式で示されるアミ
ノ酸アルキルエステルのアミノ基部分を、親水性
蛋白質分解物のカルボキシル末端にアミド結合せ
しめることを特徴とする蛋白質系乳化剤の製造
法。 R1・OR2 〔ただし、式中R1はアミノ酸残基、R2は炭素
数14から22のアルキル基を表わす。〕 2 アミノ酸と脂肪族アルコールをp−トルエン
スルフオン酸触媒下反応させた後、アルカリ性媒
質で脱塩して得られる下記一般式で示されるアミ
ノ酸アルキルエステルのアミノ基部分を、親水性
蛋白質分解物のカルボキシル末端にアミド結合せ
しめた後、得られた反応生成物を透析することを
特徴とする蛋白質系乳化剤の製造法。 R3・OR4 〔ただし、式中R3はアミノ酸残基、R4は炭素
数14から22のアルキル基を表わす。 3 アミノ酸が、グリシン、アラニン、又はロイ
シンである特許請求の範囲第2項に記載の蛋白質
系乳化剤の製造法。 4 親水性蛋白質分解物が、カゼイン、ゼラチ
ン、セリシン、可溶性コラーゲン、ゼイン、血清
アルブミン、ラクトアルブミン又は卵白アルブミ
ンである特許請求の範囲第2項又は第3項に記載
の蛋白質系乳化剤の製造法。 5 透析が、ホロフアイバー型限外濾過膜を使用
して行われるものである特許請求の範囲第2項乃
至第4項の何れかに記載の蛋白質系乳化剤の製造
法。 6 透析が、反応生成物中のエンドペプチダーゼ
活性を酸性条件で失活後25℃〜50℃の保温下円形
ハウジングに収納されたホロフアイバー型限外濾
過膜を使用して行われるものである特許請求の範
囲第2項乃至第5項の何れかに記載の蛋白質系乳
化剤の製造法。[Scope of Claims] 1. The amino group moiety of an amino acid alkyl ester represented by the following general formula obtained by reacting an amino acid and an aliphatic alcohol in the presence of a p-toluenesulfonic acid catalyst and then desalting in an alkaline medium, A method for producing a protein-based emulsifier, characterized by attaching an amide bond to the carboxyl terminal of a hydrophilic protein decomposition product. R 1 ·OR 2 [In the formula, R 1 represents an amino acid residue and R 2 represents an alkyl group having 14 to 22 carbon atoms. ] 2 After reacting an amino acid and an aliphatic alcohol under the catalyst of p-toluenesulfonic acid, the amino group portion of an amino acid alkyl ester represented by the following general formula obtained by desalting in an alkaline medium is converted into a hydrophilic protein decomposition product. 1. A method for producing a protein emulsifier, which comprises attaching an amide bond to the carboxyl terminal of a protein, and then dialyzing the resulting reaction product. R 3 ·OR 4 [In the formula, R 3 represents an amino acid residue, and R 4 represents an alkyl group having 14 to 22 carbon atoms. 3. The method for producing a protein emulsifier according to claim 2, wherein the amino acid is glycine, alanine, or leucine. 4. The method for producing a protein-based emulsifier according to claim 2 or 3, wherein the hydrophilic protein decomposition product is casein, gelatin, sericin, soluble collagen, zein, serum albumin, lactalbumin, or ovalbumin. 5. The method for producing a protein emulsifier according to any one of claims 2 to 4, wherein the dialysis is performed using a holofiber ultrafiltration membrane. 6. A patent in which dialysis is performed using a holofiber ultrafiltration membrane housed in a circular housing under heat retention at 25°C to 50°C after inactivating the endopeptidase activity in the reaction product under acidic conditions. A method for producing a protein emulsifier according to any one of claims 2 to 5.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59180177A JPS6157228A (en) | 1984-08-28 | 1984-08-28 | Preparation of proteinaceous emulsifier |
| US07/153,561 US4826818A (en) | 1983-10-26 | 1984-10-26 | Proteinaceous emulsifier, process for preparing same and emulsion type cosmetic compositions containing same |
| EP84903982A EP0160103B1 (en) | 1983-10-26 | 1984-10-26 | Proteinous emulsifier, process for its preparation, and emulsified cosmetic preparation containing same |
| PCT/JP1984/000512 WO1985001890A1 (en) | 1983-10-26 | 1984-10-26 | Proteinous emulsifier, process for its preparation, and emulsified cosmetic preparation containing same |
| DE8484903982T DE3482551D1 (en) | 1983-10-26 | 1984-10-26 | PROTEIN-CONTAINING EMULSIFIER, THE PRODUCTION THEREOF AND THE EMULSIFIED COSMETIC COMPOSITION CONTAINING THEM. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59180177A JPS6157228A (en) | 1984-08-28 | 1984-08-28 | Preparation of proteinaceous emulsifier |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6157228A JPS6157228A (en) | 1986-03-24 |
| JPH0510129B2 true JPH0510129B2 (en) | 1993-02-08 |
Family
ID=16078738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59180177A Granted JPS6157228A (en) | 1983-10-26 | 1984-08-28 | Preparation of proteinaceous emulsifier |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6157228A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100449904B1 (en) * | 2001-06-12 | 2004-09-22 | 대한민국 | The Preparation Method of Self-Assembled Sericin Nanoparticle |
-
1984
- 1984-08-28 JP JP59180177A patent/JPS6157228A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6157228A (en) | 1986-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0160103B1 (en) | Proteinous emulsifier, process for its preparation, and emulsified cosmetic preparation containing same | |
| US5458881A (en) | N-acylated derivatives of mixtures of amino acids derived from hydrolysates of cereal proteins and their applications | |
| CN108699096A (en) | Rhamnolipidamides for Hair Fragrance Retention | |
| US4451385A (en) | Agent for reducing detergent irritation to skin and eyes | |
| JPH06116300A (en) | Keratin fragment and method for producing the same | |
| JPH0226676B2 (en) | ||
| JP3139563B2 (en) | Method for producing rice bran protein-derived peptide | |
| JPS63301809A (en) | Water-soluble keratin, its production and hair cosmetic containing same | |
| JPH0510129B2 (en) | ||
| WO2001025390B1 (en) | Water unstable foam compositions | |
| JP4129069B2 (en) | Method for producing acylated peptides | |
| JPH0510130B2 (en) | ||
| WO1996005281A1 (en) | Detergent composition | |
| JPS63105000A (en) | Acylated casein-derived polypeptide of salt thereof | |
| JP4090541B2 (en) | Method for producing acylated peptides | |
| JP6254818B2 (en) | Hair treatment agent | |
| JP2972395B2 (en) | Method for producing fatty acid diethanolamide type surfactant having low diethanolamine content | |
| JPH0827192A (en) | Method for producing modified collagen and cosmetic base agent | |
| JPH10183176A (en) | Thickening of liquid cleanser | |
| JP2787469B2 (en) | Hypoallergenic cleaning composition containing an amino acid type surfactant containing two or more carboxyl groups in one molecule | |
| JPH07265075A (en) | Stable modified protease composition and stable enzyme-containing aqueous solution containing the composition | |
| JPS6092205A (en) | Emulsified cosmetic | |
| JPS6094124A (en) | Proteinic emulsifier and its manufacture | |
| JPS60175531A (en) | Proteinaceous emulsifier and its preparation | |
| JPH0657289A (en) | Improved solid detergent |